Therapy area
HIV
ATC groups J05AE, J05AF, J05AG, J05AJ, J05AR, J05AX
- Molecules
- 54
- Current shortages
- 0
Antiretroviral medicines for HIV treatment and prevention, including fixed-dose combinations used in national programmes.
Molecules
54 molecules, most requested first.
- Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor8 presentations6 brandsJ05AR03
- EntecavirHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor5 presentations4 brandsJ05AF10
- LamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor7 presentations4 brandsJ05AF05
- Tenofovir disoproxilOrphanHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor9 presentations4 brandsJ05AF07
- AtazanavirProtease Inhibitor7 presentations3 brandsJ05AE08
- DarunavirProtease Inhibitor3 presentations3 brandsJ05AE10
- MaravirocCCR5 Co-receptor Antagonist5 presentations2 brandsJ05AX09
- AbacavirHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor4 presentations2 brandsJ05AF06
- EtravirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor6 presentations2 brandsJ05AG04
- Lamivudine and ZidovudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations1 brandJ05AR01
- RaltegravirHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor7 presentations1 brandJ05AJ01
- RitonavirOrphanCytochrome P450 3A Inhibitor3 presentations3 brandsJ05AE03
- EfavirenzHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor4 presentations1 brandJ05AG03
- NevirapineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations1 brandJ05AG01
- Lopinavir and RitonavirProtease Inhibitor5 presentations3 brandsJ05AR10
- ZidovudineOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor6 presentations1 brandJ05AF01
- Abacavir and LamivudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR02
- Efavirenz, Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation3 brandsJ05AR06
- LetermovirOrphanCytomegalovirus DNA Terminase Complex Inhibitor6 presentations1 brandJ05AX18
- LenacapavirHuman Immunodeficiency Virus 1 Capsid Inhibitor4 presentations4 brandsJ05AX31
- Ledipasvir and SofosbuvirOrphanHepatitis C Virus NS5A Inhibitor5 presentations1 brandJ05AP51
- DolutegravirHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor4 presentations2 brandsJ05AX12
- Bictegravir, Emtricitabine and Tenofovir alafenamideOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations2 brandsJ05AR20
- EmtricitabineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations2 brandsJ05AF09
- RilpivirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations3 brandsJ05AG05
- SofosbuvirOrphanHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor4 presentations2 brandsJ05AP08
- Emtricitabine, Rilpivirine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations2 brandsJ05AR08
- FosamprenavirProtease Inhibitor1 presentationJ05AE07
- Nirmatrelvir and Ritonavir1 presentation2 brandsJ05AE30
- Emtricitabine and Tenofovir alafenamideOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations3 brandsJ05AR17
- CabotegravirHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor2 presentations2 brandsJ05AJ04
- NelfinavirProtease Inhibitor2 presentations1 brandJ05AE04
- TecovirimatOrphanOrthopoxvirus VP37 Envelope Wrapping Protein Inhibitor2 presentations2 brandsJ05AX24
- Adefovir dipivoxilHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentationJ05AF08
- Dolutegravir and LamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR
- DoravirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AG06
- MaribavirOrphanCytomegalovirus pUL97 Kinase Inhibitor1 presentation2 brandsJ05AX10
- Abacavir, Dolutegravir and LamivudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR13
- Atazanavir and CobicistatCytochrome P450 3A Inhibitor1 presentation2 brandsJ05AR15
- Cobicistat, Darunavir, Emtricitabine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR22
- Cobicistat, Elvitegravir, Emtricitabine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR
- Cobicistat, Elvitegravir, Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR09
- Dolutegravir and RilpivirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR21
- Doravirine, Lamivudine and Tenofovir disoproxilHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR
- Emtricitabine, Rilpivirine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation3 brandsJ05AR19
- Ensitrelvir1 presentation2 brandsJ05AE16
- Fostemsavir1 presentation1 brandJ05AX
- IbalizumabOrphanAntibodies1 presentation1 brandJ05AX23
- Tenofovir alafenamideHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AF13
- Abacavir, Lamivudine and ZidovudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentationJ05AR04
- Cobicistat and DarunavirJ05AR14
- Enfuvirtide1 brandJ05AX07
- Ledispavir and Sofosbuvir1 brandJ05AX65
- Tipranavir1 brandJ05AE09
Conditions
Country notes
Import rules differ by country, for example permits for unregistered medicines or named-patient routes. Each country guide explains who applies, the documents needed and typical timelines.
All import guidesFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Sourcing HIV medicines?
Add the molecules you need to one request. We check each country's import rules before we quote.